Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Stempel

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Allergy and Clinical Immunology|March 19, 2002
Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costsDavid A Stempel, John C O'Donnell, Jay W Meyer
Pediatric Pulmonology|July 13, 2005
Treatment patterns for pediatric asthma prior to and after emergency department eventsDavid A Stempel, Trent P McLaughlin, Richard H Stanford
The New England Journal of Medicine|September 15, 2016
Safety Study of Salmeterol in Asthma in AdultsDavid A Stempel, Anne M Yeakey, Steven J Pascoe
The New England Journal of Medicine|December 14, 2016
Salmeterol and Fluticasone Propionate in Children with AsthmaDavid A Stempel, Stanley J Szefler, Steven J Pascoe
The Journal of Allergy and Clinical Immunology|January 18, 2011
Asthma control differences between inhaled corticosteroids likely related to differences in patient severityRichard H Stanford, Steven W Yancey, David A Stempel
Chest|July 14, 2004
Treatment patterns in the months prior to and after asthma-related emergency department visitDavid A Stempel, Craig S Roberts, Richard H Stanford
The Journal of Allergy and Clinical Immunology. in Practice|May 12, 2019
Asthma Control-Time to Rethink Definitions and CriteriaGiselle Mosnaim, Hilary Stempel, Stanley J Szefler, et al.
Current Medical Research and Opinion|January 6, 2006
Assessment of asthma control in a general population of asthmaticsMichael Lenoir, Alyssa Williamson, Richard H Stanford, et al.
Current Medical Research and Opinion|April 1, 2006
Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthmaDavid A Stempel, Aylin Altan Riedel, Jacqueline R Carranza Rosenzweig
Respiratory Medicine|October 27, 2019
Higher short-acting beta-agonist use is associated with greater COPD burdenRahul Gondalia, Bruce G Bender, Benjamin Theye, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Allergy and Clinical Immunology|March 19, 2002
Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costsDavid A Stempel, John C O'Donnell, Jay W Meyer
Pediatric Pulmonology|July 13, 2005
Treatment patterns for pediatric asthma prior to and after emergency department eventsDavid A Stempel, Trent P McLaughlin, Richard H Stanford
The New England Journal of Medicine|September 15, 2016
Safety Study of Salmeterol in Asthma in AdultsDavid A Stempel, Anne M Yeakey, Steven J Pascoe
The New England Journal of Medicine|December 14, 2016
Salmeterol and Fluticasone Propionate in Children with AsthmaDavid A Stempel, Stanley J Szefler, Steven J Pascoe
The Journal of Allergy and Clinical Immunology|January 18, 2011
Asthma control differences between inhaled corticosteroids likely related to differences in patient severityRichard H Stanford, Steven W Yancey, David A Stempel
Chest|July 14, 2004
Treatment patterns in the months prior to and after asthma-related emergency department visitDavid A Stempel, Craig S Roberts, Richard H Stanford
The Journal of Allergy and Clinical Immunology. in Practice|May 12, 2019
Asthma Control-Time to Rethink Definitions and CriteriaGiselle Mosnaim, Hilary Stempel, Stanley J Szefler, et al.
Current Medical Research and Opinion|January 6, 2006
Assessment of asthma control in a general population of asthmaticsMichael Lenoir, Alyssa Williamson, Richard H Stanford, et al.
Current Medical Research and Opinion|April 1, 2006
Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthmaDavid A Stempel, Aylin Altan Riedel, Jacqueline R Carranza Rosenzweig
Respiratory Medicine|October 27, 2019
Higher short-acting beta-agonist use is associated with greater COPD burdenRahul Gondalia, Bruce G Bender, Benjamin Theye, et al.
Pageof 9